https://www.selleckchem.com/pr....oducts/gsk-lsd1-2hcl
Management of hypoxemia in patients with severe COVID-19 respiratory failure is based on the guideline recommendations for specific SpO targets. However, limited data exist on systemic O utilization. The objective of this study was to examine systemic O utilization in a case series of patients with this disease. Between March 24, and April 9, 2020, 8 patients intubated for severe COVID-19 respiratory failure had near-simultaneous drawing of arterial blood gas (ABG), central venous blood gas (cVBG), and central venous oxygen satura
Like
Comment
Share
